Role of medicinal plants in free radical induced sickle cell anemia

Paper Details

Review Paper 01/07/2013
Views (330) Download (14)
current_issue_feature_image
publication_file

Role of medicinal plants in free radical induced sickle cell anemia

Rahmat Ali Khan, Mushtaq Ahmed, Muhammad Imran Khan, Nawshad Muhammad, Muhammad Rashid Khan, Amin Ullah, Syed Rehman, Nadia Mushtaq, Akhlaq Ahmed, Farman Ullah Khan, Muhammad Shahzad Shifa
Int. J. Biosci.3( 7), 188-194, July 2013.
Certificate: IJB 2013 [Generate Certificate]

Abstract

Sickle cell disease (SCD) is a common recessively inherited disorder of hemoglobin affecting peoples everywhere in the world. The homozygous state (SS) is associated with complications and reduced life anticipation. The symptoms including, shortness of breath, heart palpitations, abdominal pains, aches and pains in the muscle. One cause of this disease is oxidative stress which is an imbalance between the reactive oxygen species and the potential of the body to neutralize these reactive species. An anti-oxidant is a substance which prevents oxidative stress by scavenging the free radicals. Medicinal plants are good and rich sources of natural antioxidants. Crude extracts from plants have been used in treating many diseases since ancient times. Various advances in scientific research on the use of plants and herbs explore the beneficial aspects of traditional medicine. This review highlights the role of oxidative stress in the progression and development of Sickle Cell Disease (SCD) and reviews the available literature reporting antisickling properties of a number of plants extracts.

VIEWS 5

Abdulmalik O, Osafa MK, Chen Q, Yang J, Brugnara C, Ohene-Frempong K,Abraham DJ, Asakura T. 2005. 5-hydroxymethyl-2-furfural modifies intracellular sickle hemoglobin and inhibits sickling of red blood cells. Britistish Journal of Haematology 4, 552-561.

Adaikpoh MA, Orhue NEJ, Igbe I. 2007. The protective role of Scoparia dulcis on tissue antioxidant defense system of rats exposed to cadmium. African Journal of Biotechnology 12, 1192-1196.

Agarwal MB, Mehta BC. 1980. Sickle-syndromes: A study of 44 cases from Bombay. Indian Pediatr 17, 793–6.

Agarwal MB. 2005 The burden of haemoglobinopathies in India—time to wake up? J Assoc Physicians India 53, 1017–18.

Agbai, O. 1986. Antisickling effect of dietary thiocyanate in prophylactic control of sickle cell anemia. Journal of the National Medical Association 1053 – 56.

Ahmed M, Jakupovic J. 1990. Ditrepenoids from Scoparia dulcis L. Phytochemistry 3035- 3037.

Akojie FO, Fung LW. 1992. Antisickling activity of hydroxybenzoic acids in Cajanus cajan. Planta Medica 317-320.

Bewaji  CO,  Olorunsogoand  EA.  Bababumi. 1985 . Sickle cell membrane-bound (Ca2+ and Mg2+)- ATPase: Activation by 3,4-dihydro-2, 2-dimethyl-2H-1-1-benzopyran-6- butyric acid. A novel antisickling agent.Cell Calcium 6, 237- 244.

Brugnara C. 2000. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Critical Reviews in Clinical Laboratory Sciences 93-130.

Carrell RW, Winterbourn CC, Rachmilewitz EA. 1975. Activated oxygen and hemolysis. British Journal of Haematology 30, 259-264.

Chiu D, Vichinsky E, Yee M, Kleman K, Lubin B. 1982. Peroxidation, vitamin E, and sickle-cell anemia. Ann NY Acad Sci 393, 323–35.

Corash L, Spielberg S, Bartsocas C. 1980. Reducedchronichaemo- lysisduring highdosevitamin E administration in Mediterranean type glucose-6-phosphate dehydrogenase deficiency. New England Journal of Medicine 303, 416-420.

Ekeke GI, Shode FO. 1985. The reversion of sickled cells by Cajanus cajan. Planta Medica 504-507

Elekwa I, Monanu MO, Anosike EO. 2005. In vitro effects of aqueous extracts of Zanthxylum macrophyla roots on adenosine triphosphatases from human erythrocytes of different genotypes. Biokemistri, 19-25.

Elekwa I, Monanu MO, Anosike EO. 2003. Studies on the effect of aqueous extracts of Garcinia kola seed on the human erythrocytes adenosine triphosphatase of HbAA, HbAS, and HbSS genotypes. Global Journal of Medical Science 107-114.

Hafez M, Amar ES, Zedan M, Hammad , Sorour AH, el-Desouky ES , Gamil N. 1986. Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis. The Journal of Pediatric 558-561.

Hayashi, T. 1987. Structures of new diterpenoids from Paraguayan crude drug Typycha Kuratu (S.dl). Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 29, 511-551

Hayashi, T. 1990 Antiviral agents of plant orgin. III. Scopadulin: A novel tertracyclic diterpene Scoparia dulcis L. Chemical & Pharmaceutical Bulletin (Tokoyo) 945-946.

Hebbel, RP. 1985. Auto-oxidation and a membrane-associated “Fenton reagent”. A possible explanation for development of membrane lesions in sickle erythrocytes. Clinics in Hematology 14, 129-140.

Honig GR, Farnsworth NR, Ferenc C, Vida LN. 1975 Evaluation of Fagara zanthyloides root extract in sickle cell anemia blood in vitro. Lloydia 387-390.

Ingram VM. 1956 A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 178,792–4.

Iwu MM, Igboko AO, Onwubiko H, Ndu UE. 1988. Effect of cajaminose from Cajanus cajan on gelation and oxygen af_nity of sickle cell haemoglobin. Journal of Ethnopharmacology, 99-104.

Iyamu EW, Turner EA, Asakura T. 2002. In vitro effects of NIPRISAN (Nix-0699). a naturally occurring, potent antisickling agent. British Journal of Haematology, 337-343.

Johnson GJ, Vatassery GR, Finkel B, Allen DW. 1983. High-dose vitamin E does not decrease the rate of chronic hemolysisin G-6-PD deficiency. New England Journal of Medicine 303, 432-436.

Kawasaki M. 1987. Structure of Scoparic acid A, a new labdane type diterpenoid from a Paraguayan crude drug “Typycha Kuratu” (Scoparia dulcis L.) Tetrahedron Letters 3693-3696.

Malowany JI, Butany J February. 2011 Pathology of sickle cell disease”. Seminars in Diagnostic Pathology 49–55.

Mgbemene CN, Ohiri FC. 1999. Anti-sickling potential of Terminalia catappa leaf extract. Pharmaceutical Biology 152-154.

Moody JO, Robert VA, Connolly JD, Houghton PJ. 2003. Anitinflammatory activities of methanol extracts and an isolated furanoditerpene constituent of Sphenocentrum jollyanum Pierre (Menispermaceae). Journal of Ethnopharmacology 67-91.

Mpiana PT, Tshibangu DST, Shehonde OM, Ngbolua KN. 2007. In vitro antidrepanocytary activity (antisickle cell anemia) of some Congolese plants. Phytomedicine 192-195

Newman GJ, Newman TB, Bowie LJ, Mendelsohn J. (1979) An examination of the role of vitamin E in G-6-PD deficiency. Clinical Biochemistry 12, 149-151.

Nur E, Biemond BJ, Otten HM, Brandjes DP Schnog JB. 2011. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. American Journal of Hematology 86, 484–489.

Ohnishi ST, Ohnishi T. 2001. In vitro effects of AGED garlic extract and other nutritional supplements on sickle cell erythrocytes.

Ojo OO, Kabutu FR, Bello M, Babayo U. 2006. Inhibition of paracetamol-induced oxidative stress in rats by extracts of lemongrass (Cymbropogon citratus) and green tea (Camellia sinensis) in rats. African Journal of Biotechnology, 1227-123.

Olagunjua JA, Adeneyeb BS, Fagbohunkac NA, Bisugac AO, Ketikuc AS, Benebod O M. 2009. Olufowobic, A. G. Adeoyec, M. A. Alimic and A. G. Adelekec. Nephroprotective activities of the aqueous seed extract of Carica papaya Linn. in carbon tetrachloride induced renal njured Wistar rats: a dose- and time-dependent study Biology and Medicine 11-19.

Orhue NE, Nwanze EA, Okafor A. 2005. Serum total protein, albumin and globulin levels in Trypanosoma brucei infected rabbits. Effects of orally administered Scoparia dulcis African Journal of Biotechnology 1152-1155

Orhue NE, Nwanze EAC. 2006. Scoparia dulcis reduces the severity of Trypanosome brucei induced hyperlipidemia in the rabbit. African Journal of Biotechnology,883-887

Platt OS, Brambilla DJ, Rosse WF. 1994 . “Mortality in sickle cell disease. Life expectancy and risk factors for early death”. 330 , 1639–44

Platt OS, Brambilla DJ, Rosse WF. 1994 . “Mortality in sickle cell disease. Life expectancy and risk factors for early death”. 330 , 1639–44.

Rajaprabhu D, Rajesh R, Jeyakumar R, Buddhan S, Ganesan B and Anandan R. 2007. Protective effect of Picrorhiza kurroa on antioxidant defense status in adriamycin-induced cardiomyopathy in rats, 080-085.

Sarkadi, B 1979, B., D. Tosteson, G. Giebisch, D. Tosteson, and H. 1979. Ussing, (eds), Springer,and Heidelberg. In Membrane Transport in Biology 2, 117−160.

Semiz A, Sen A. 2007. Antioxidant and chemoprotective properties of Momordica charantia L. (bitter melon) fruit extract. African Journal of Biotechnology 6, 273-277.

Sofowora EA, Issac-Sodeye WA. 1971. Reversal of sickling and crenation in erthrocytes by the root of Fagara xanthoxyloides. Lioydia 34, 383.

Takasu J, Uykimpang R, Sunga M, Amaase H, Nihara Y. 2002. Aged garlic extract therapy for sickle cell anemia patients. BMC Blood Disorders 2(3)

Vanhaelen-Fastre R, Vahaelen M, Lo I, Toppet M, Ferster A, Fondu P. 1999. In vitro antisickling activity of a rearranged limonoid isolated from Khaya senegalensis; Planta Medica 209-212.

Wambebe C, Khamofu H, Momoh JA. 2001. Double-blind, placebo-controlled, randomized cross-over clinical trial of NIPRISAN in patients with sickle cell disorder. Phytomedicine 252-61.

Wang WC, Greer JP, Foerster J, Lukens JN, Rodgers GM , Paraskevas F, Glader B. 2004. Sickle cell anemia and other sickling syndromes. In:. (eds). Wintrobe’s clinical hematology. 11th ed. Philadelphia:Lippincott Williams and Wilkins, 1264–1311.

Wellems TE, Hayton K, Fairhurst RM September. 2009. “The impact of malaria parasitism: from corpuscles to communities”. Journal of Clinical Investigation 119, 2496–505.